Regulated Heat Combined with Impedance Spectroscopy to Improve and Control Electroporative DNA Delivery to the Skin in Vivo
Regulated Heat Combined with Impedance Spectroscopy to Improve and Control Electroporative DNA Delivery to the Skin in Vivo
批准号:
10443219
负责人:
Mark J. Jaroszeski
金额:
$5.38万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2022-01-31
关键词:
AddressAffectAnimal ModelAnimalsAreaBiologicalCaviaCell membraneCellsCharacteristicsClinicalClinical TrialsCombined Modality TherapyComplexCustomDNADNA deliveryDataDevicesDoseElectricityElectrodesElectroporationElementsFactor IXFeedbackFrequenciesGene DeliveryGenesGoalsHeatingHepatitis B Surface AntigensHistologicImageImmune responseIndividualInvestigationKineticsKnowledgeLeadLuciferasesMeasurementMeasuresMediatingMembrane FluidityMethodsModelingNatureOutcomeOutcome StudyPatientsPersonsPhysiologic pulsePlasmidsProceduresProcessPropertyPublic HealthPublishingReporterReproducibilityResearchResearch PersonnelSerumSkinSkin TemperatureSpectrum AnalysisSystemTechnologyTemperatureTherapeuticTimeTissuesVariantWorkbaseclinical applicationdesignelectric fieldelectric impedanceexperimental studygene therapyhuman tissueimprovedin vivoindividual variationphysical processplasmid DNApreclinical studyprimary outcomeresponsesuccesstemporal measurementtherapeutic DNAtherapeutic proteintransgene deliverytreatment siteuptakevoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT:
Gene therapy is not yet a reality. One obstacle and generalization is that methods for delivering genes in vivo
have not yet achieved a desired level of reliability and control. In vivo electroporation is a method for
delivering DNA that has been successful in preclinical studies. These have been performed using the
technology for a variety of applications. Collectively, they prove that the physical basis of the method makes it
adaptable to any tissue. These studies paved the way for over 100 clinical trials that use the technology in
vivo. Thus, there are clear research and clinical applications for this DNA delivery method. But, the method
could be improved because it still suffers from lack of control/reliability. One reason for this is that the
characteristics of the electric pulses used to induce DNA uptake are normally fixed for a particular tissue type
based upon optimization in animal models. These may have little translatability to analogous tissues in clinical
settings as models may not be identical to human tissues. In addition, there is variation from individual to
individual. Thus, using the same electric pulses (or dose of electricity) to deliver DNA to a particular type of
tissue is not likely to be optimal each time the method is used in that tissue type. Unfortunately, this is the
current state of the art. A means of customizing/adapting electrical treatment in real-time could circumvent this
issue and add to the efficiency/reliability of the method. Another issue with the state of the art is that in vivo
electroporation affects cell membranes and has traditionally been performed at ambient temperature.
Moderately increased temperatures could affect the results as they influence membrane fluidity. This
proposed R01 has been designed to address these two aspects in combination to improve delivery in skin.
The basis for this study is preliminary data that indicate approximately 10-fold increases in delivery when
customized pulses or moderate temperature increases are used alone The research plan includes
implementing electroporation pulse delivery that is dynamic rather than fixed while controlling the temperature
at the skin treatment site. The system will utilize real-time measurements of tissue electrical impedance
changes that result from electroporation pulses. The system will be capable of applying multiple electric
pulses, measure impedance between pulses, and make adjustments to the electrical treatment to control the
delivery procedure while maintaining a user set moderately elevated temperature. It is expected that reliability
and control will be increased by achieving higher delivery/expression of the DNA and reduced variation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulated Heat Combined with Impedance Spectroscopy to Improve and Control Electroporative DNA Delivery to the Skin in Vivo
-
批准号:9910401
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2019
-
负责人:Mark J. Jaroszeski
-
依托单位:
Regulated Heat Combined with Impedance Spectroscopy to Improve and Control Electroporative DNA Delivery to the Skin in Vivo
-
批准号:10443308
-
项目类别:
-
资助金额:$5.38万
-
财政年份:2019
-
负责人:Mark J. Jaroszeski
-
依托单位:
Regulated Heat Combined with Impedance Spectroscopy to Improve and Control Electroporative DNA Delivery to the Skin in Vivo
-
批准号:10375335
-
项目类别:
-
资助金额:$36.78万
-
财政年份:2019
-
负责人:Mark J. Jaroszeski
-
依托单位:
Impedance Changes as an Indicator of Successful Skin Electroporative DNA delivery
-
批准号:8230675
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2011
-
负责人:Mark J. Jaroszeski
-
依托单位:
Impedance Changes as an Indicator of Successful Skin Electroporative DNA delivery
-
批准号:8095437
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2011
-
负责人:Mark J. Jaroszeski
-
依托单位:
Development of Streamed Ion Deposition for Efficient Plasmid DNA Delivery
-
批准号:7790162
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2010
-
负责人:Mark J. Jaroszeski
-
依托单位:
Topical Charge Driven DNA Delivery to the Skin
-
批准号:7978722
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2010
-
负责人:Mark J. Jaroszeski
-
依托单位:
Development of Streamed Ion Deposition for Efficient Plasmid DNA Delivery
-
批准号:8120328
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2010
-
负责人:Mark J. Jaroszeski
-
依托单位:
Topical Charge Driven DNA Delivery to the Skin
-
批准号:8105034
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2010
-
负责人:Mark J. Jaroszeski
-
依托单位:
USF MARC U-STAR Scholar Program
-
批准号:7076988
-
项目类别:
-
资助金额:$39.76万
-
财政年份:2005
-
负责人:Mark J. Jaroszeski
-
依托单位:
USF MARC U-STAR Scholar Program
-
批准号:7237241
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2005
-
负责人:Mark J. Jaroszeski
-
依托单位:
USF MARC U-STAR Scholar Program
-
批准号:6894436
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2005
-
负责人:Mark J. Jaroszeski
-
依托单位:
Corona Charge for Drug and DNA Delivery to Cancer Cells
-
批准号:6676015
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2003
-
负责人:Mark J. Jaroszeski
-
依托单位:
Corona Charge for Drug and DNA Deliver to Cancer Cells
-
批准号:6781804
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2003
-
负责人:Mark J. Jaroszeski
-
依托单位:
Pine Cone Extract as an Adjuvant to Chemotherapy
-
批准号:6508245
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2002
-
负责人:Mark J. Jaroszeski
-
依托单位:
Pine Cone Extract as an Adjuvant to Chemotherapy
-
批准号:6603930
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2002
-
负责人:Mark J. Jaroszeski
-
依托单位:
Feasibility of DNA Delivery with Microelectrodes
-
批准号:6549881
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:Mark J. Jaroszeski
-
依托单位:
海外基金